CLINICAL USE OF GROWTH-FACTORS

被引：13

作者：

BRONCHUD, MH ^{[1
]}

DEXTER, TM ^{[1
]}

机构：

[1] PATERSON INST CANC RES, DEPT EXPTL HAEMATOL, MACHESTER, ENGLAND

来源：

BRITISH MEDICAL BULLETIN | 1989年 / 45卷 / 02期

关键词：

D O I：

10.1093/oxfordjournals.bmb.a072345

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：590 / 599

页数：10

共 34 条

[1]

ANTMAN K, 1988, P AN M AM SOC CLIN, V7, P160

[2] INTERLEUKIN-2 RECEPTOR TARGETED CYTO-TOXICITY INTERLEUKIN-2 RECEPTOR MEDIATED ACTION OF A DIPHTHERIA-TOXIN RELATED INTERLEUKIN-2 FUSION PROTEIN [J].

BACHA, P ;

WILLIAMS, DP ;

WATERS, C ;

WILLIAMS, JM ;

MURPHY, JR ;

STROM, TB .

JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 167 (02) :612-622

[3]

BERRIDGE MV, 1987, BLOOD S, V70, pA348

[4]

BEUTLER B, 1987, NEW ENGL J MED, V316, P379

[5] EFFECT OF RECOMBINANT HUMAN GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR ON HEMATOPOIETIC RECONSTITUTION AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION [J].

BRANDT, SJ ;

PETERS, WP ;

ATWATER, SK ;

KURTZBERG, J ;

BOROWITZ, MJ ;

JONES, RB ;

SHPALL, EJ ;

BAST, RC ;

GILBERT, CJ ;

OETTE, DH .

NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (14) :869-876

[6] INVITRO AND INVIVO ANALYSIS OF THE EFFECTS OF RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR IN PATIENTS [J].

BRONCHUD, MH ;

POTTER, MR ;

MORGENSTERN, G ;

BLASCO, MJ ;

SCARFFE, JH ;

THATCHER, N ;

CROWTHER, D ;

SOUZA, LM ;

ALTON, NK ;

TESTA, NG ;

DEXTER, TM .

BRITISH JOURNAL OF CANCER, 1988, 58 (01) :64-69

[7] PHASE-I/II STUDY OF RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR IN PATIENTS RECEIVING INTENSIVE CHEMOTHERAPY FOR SMALL CELL LUNG-CANCER [J].

BRONCHUD, MH ;

SCARFFE, JH ;

THATCHER, N ;

CROWTHER, D ;

SOUZA, LM ;

ALTON, NK ;

TESTA, NG ;

DEXTER, TM .

BRITISH JOURNAL OF CANCER, 1987, 56 (06) :809-813

[8] CYCLOSPORIN-A MEDIATES IMMUNOSUPPRESSION OF PRIMARY CYTO-TOXIC T-CELL RESPONSES BY IMPAIRING THE RELEASE OF INTERLEUKIN-1 AND INTERLEUKIN-2 [J].

BUNJES, D ;

HARDT, C ;

ROLLINGHOFF, M ;

WAGNER, H .

EUROPEAN JOURNAL OF IMMUNOLOGY, 1981, 11 (08) :657-661

[9] BENEFITS AND RISKS OF PROTRACTED TREATMENT WITH HUMAN RECOMBINANT ERYTHROPOIETIN IN PATIENTS HAVING HEMODIALYSIS [J].

CASATI, S ;

PASSERINI, P ;

CAMPISE, MR ;

GRAZIANI, G ;

CESANA, B ;

PERISIC, M ;

PONTICELLI, C .

BMJ-BRITISH MEDICAL JOURNAL, 1987, 295 (6605) :1017-1020

[10]

DEDHAR S, 1988, P AM ASSOC CANC RES, V29, P51

← 1 2 3 4 →